Direct Plan · Growth · Mid Cap · Scheme code 147445
NAV₹40.0860as on 27 Oct 2026
Fund houseMirae Asset Mutual Fund
CategoryMid Cap
Plan & optionDirect · Growth
History7.1 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
2.45
8.47
11.65
16.88
18.33
17.47
24.09
—
23.82
Nifty Midcap 150 benchmark
1.72
4.38
7.84
13.13
17.93
18.11
—
—
22.88
Mid Cap category median
—
—
—
-3.33
15.41
13.12
—
15.08
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
18.0%
0.66
0.99
0.99
0.52%
-37.4%
96.80
Nifty Midcap 150 benchmark
17.9%
0.64
0.98
—
—
-37.2%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
1,503
-4.3%
19.3%
119.6%
3%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
101%
100%
0.98
3.2%
0.13
11.45
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 36 months this scheme and
Nifty Midcap 150 share.
Mirae Asset Midcap Fund
Direct Plan · Growth
Allocation
By asset
Equity
97.56%
Cash & Equivalents
2.19%
Mutual Fund Units
0.25%
By market cap
Large Cap
11.76%
Mid Cap
67.94%
Small Cap
15.63%
Unclassified
2.48%
Concentration
Number of stocks
65
Top 5 stocks
17.78%
Top 10 stocks
31.55%
Top 20 stocks
52.90%
Lines in the filing
67
Largest holding
4.31%
Largest sector
Pharmaceuticals & Biotechnology 11.47%
Effective stocks
48.9
Sectors held
32
Cash
2.19%
Effective stocks is what the concentration works out to: a fund holding
65 names but most of its money in a few
behaves like a fund of 49. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
11.47%
Banks
8.25%
Consumer Durables
7.76%
Retailing
6.41%
Finance
6.17%
Auto Components
5.24%
Capital Markets
4.85%
Transport Services
4.47%
Ferrous Metals
3.76%
Financial Technology (Fintech)
3.60%
Realty
3.11%
Healthcare Services
3.08%
Automobiles
2.89%
IT - Software
2.86%
Cement & Cement Products
2.54%
Telecom - Services
2.52%
Cash & Equivalents
2.19%
Insurance
2.14%
Chemicals & Petrochemicals
2.13%
Non - Ferrous Metals
1.75%
Mirae Asset Midcap Fund
Direct Plan · Growth · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
4,253,201
842
4.31%
2
Steel Authority of India Ltd.
Ferrous Metals
40,441,210
734
3.76%
3
HDB Financial Services Ltd.
Finance
10,572,895
657
3.36%
4
Lupin Ltd.
Pharmaceuticals & Biotechnology
3,218,048
653
3.34%
5
Delhivery Ltd.
Transport Services
14,346,353
588
3.01%
6
Hero MotoCorp Ltd.
Automobiles
1,078,292
565
2.89%
7
Persistent Systems Ltd.
IT - Software
1,057,566
558
2.86%
8
IndusInd Bank Ltd.
Banks
5,825,362
525
2.69%
9
Swiggy Ltd.
Retailing
20,847,043
521
2.67%
10
Dixon Technologies (India) Ltd.
Consumer Durables
396,910
520
2.66%
11
Dalmia Bharat Ltd.
Cement & Cement Products
2,943,408
496
2.54%
12
Tata Communications Ltd.
Telecom - Services
2,970,865
492
2.52%
13
Bharat Forge Ltd.
Auto Components
2,312,805
445
2.28%
14
Narayana Hrudayalaya Ltd.
Healthcare Services
2,328,229
417
2.13%
15
Axis Bank Ltd.
Banks
3,398,038
417
2.13%
16
Prestige Estates Projects Ltd.
Realty
2,785,803
413
2.11%
17
The Federal Bank Ltd.
Banks
11,889,471
377
1.93%
18
Voltas Ltd.
Consumer Durables
3,502,512
375
1.92%
19
BSE Ltd.
Capital Markets
1,198,992
371
1.90%
20
L&T Finance Ltd.
Finance
13,913,647
369
1.89%
21
One 97 Communications Ltd.
Financial Technology (Fintech)
2,183,826
366
1.88%
22
TREPS
Unclassified
—
359
1.84%
23
Mankind Pharma Ltd.
Pharmaceuticals & Biotechnology
1,431,251
358
1.83%
24
Vedanta Aluminium Metal Ltd.
Non - Ferrous Metals
8,259,270
341
1.75%
25
PB Fintech Ltd.
Financial Technology (Fintech)
3,169,724
337
1.73%
26
Bharat Heavy Electricals Ltd.
Electrical Equipment
7,899,475
328
1.68%
27
PI Industries Ltd.
Fertilizers & Agrochemicals
1,390,377
321
1.64%
28
3M India Ltd.
Diversified
97,887
315
1.61%
29
Gland Pharma Ltd.
Pharmaceuticals & Biotechnology
1,038,228
301
1.54%
30
Tata Power Company Ltd.
Power
8,351,535
300
1.53%
Mirae Asset Midcap Fund
Direct Plan · Growth · where the money sits
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹947,616
₹347,616
18.35%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 28 Oct 2026.